Concerns for potential vulnerability to manganese (Mn) neurotoxicity during fetal and neonatal development have been raised due to increased needs for Mn for normal growth, different sources of exposure to Mn, and pharmacokinetic differences between the young and adults. A physiologically based pharmacokinetic (PBPK) model for Mn during human gestation and lactation was developed to predict Mn in fetal and neonatal brain using a parallelogram approach based upon extrapolation across life stages in rats and cross-species extrapolation to humans. Based on the rodent modeling, key physiological processes controlling Mn kinetics during gestation and lactation were incorporated, including alterations in Mn uptake, excretion, tissue-specific distributions, and placental and lactational transfer of Mn. Parameters for Mn kinetics were estimated based on human Mn data for milk, placenta, and fetal/neonatal tissues, along with allometric scaling from the human adult model. The model was evaluated by comparison with published Mn levels in cord blood, milk, and infant blood. Maternal Mn homeostasis during pregnancy and lactation, placenta and milk Mn, and fetal/ neonatal tissue Mn were simulated for normal dietary intake and with inhalation exposure to environmental Mn. Model predictions indicate similar or lower internal exposures to Mn in the brains of fetus/neonate compared with the adult at or above typical environmental air Mn concentrations. This PBPK approach can assess expected Mn tissue concentration during early life and compares contributions of different Mn sources, such as breast or cow milk, formula, food, drinking water, and inhalation, with tissue concentration.
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Manganese (Mn), an essential element present in all tissues, is crucial for a number of biological and physiological processes in the body, including immune function, regulation of cellular energy, reproduction, digestion, bone growth, and blood clotting Aschner et al., 2007) . Mn plays an important role as a cofactor for many enzymic reactions including amino acid, lipid, protein, and carbohydrate metabolism. It is also utilized in various antioxidant enzymes, such as superoxide dismutase, and activates glycosyltransferase, a crucial step for bone and connective tissue growth (Erikson et al., 2007) . As such, Mn plays a critical role in normal prenatal and neonatal development, and its deficiency may cause developmental deficits such as skeletal abnormalities and abnormal brain function (Hurley, 1981) .
The primary route of Mn intake is through food. In the general population, average dietary intake has been estimated to be less than 5 mg Mn/day with a range of 0.9-10 mg Mn/day . Normally, only about 1-5% of ingested Mn is absorbed in adults, with women absorbing a significantly higher percentage of dietary Mn than men Finley et al., 1994) . In general, tissue Mn concentrations are maintained at relatively constant levels despite the wide range of daily Mn intake. Homeostasis is achieved by the tightly controlled regulation of absorption of Mn in the gut and inducible biliary excretion of Mn. However, exposure to high air Mn concentrations, as might occur in occupational settings, could overwhelm homeostatic controls and results in elevations in tissue Mn concentrations. Increased Mn in the brain, especially in dopamine-rich brain regions that control muscle movement, leads to neuropsychiatric and motor disturbances. In humans, severe Mn-induced neurotoxicity is commonly referred to as manganism, a type of parkinsonism that is distinct from clinical Parkinson's disease . The primary target regions in manganism are the globus pallidus and striatum of the basal ganglia, whereas neurodegeneration in Parkinson's disease occurs mainly in the substantia nigra (Cersosimo and Koller, 2006; Walter et al., 2003) . Although the primary source of Mn intoxication in humans occurs via inhalation in occupational settings, such as mining and welding, homeostatic control mechanisms can also be disturbed by other sources of overexposure, such as high concentrations in drinking water, total parenteral nutrition (TPN), and in patients with compromised hepatobiliary function .
Concerns for potential vulnerability to Mn neurotoxicity during fetal and neonatal development have been raised mainly because of increased needs for Mn during intrauterine and postnatal growth and pharmacokinetic differences between the young and adult. In addition, compared with the adult, sources of exposure to Mn are different during different stages of development: placental transfer, breast milk, and infant formula fortified with essential metals (Erikson et al., 2007) . Because the body Mn homeostasis is mainly achieved at the level of absorption of Mn in the gut and biliary excretion of this element , it is important to understand any differences in these pharmacokinetic processes in early ages compared with the adult. Several factors have been considered to potentially predispose children to enhanced Mn uptake and subsequent toxic effects compared with adults. These factors include higher intestinal absorption of ingested Mn in children than in adults (Dorner et al., 1989; Keen et al., 1986) and a low basal excretion rate observed in young animals (Ballatori et al., 1987) . Along with the observation of enhanced delivery of Mn to the neonatal brain (Takeda et al., 1999) , these pharmacokinetic differences are often regarded as a reflection of poorly developed homeostatic mechanisms in neonatal animals, another factor that could result in greater uptake of Mn by the neonatal brain. However, these differences in Mn pharmacokinetics observed in early ages should be evaluated with caution by taking into account the fact that Mn is essential for normal development. In fact, the avid retention of Mn seen in the neonates is likely a consequence of the scarcity of this essential element in diet (Aschner, 2000) . The key question to be addressed to properly assess the potential risks of Mn in infants and children is to what extent these neonatal homeostatic controls are able to respond when challenged with Mn overexposure. In this context, we have developed a physiologically based pharmacokinetic (PBPK) model in order to integrate currently available information on Mn kinetics during gestation and lactation and consequently to describe the homeostatic controls of Mn during human development under various environmental exposure conditions.
METHODS

Approach
The experience gained from extrapolation of the pharmacokinetics of Mn across life stages in the rat (Yoon et al., 2009a,b) as well as the cross-species extrapolation from the rat to monkey (Nong et al., 2009 ) and then to human adult (Schroeter et al., 2011) provided confidence for building a series of PBPK models for describing Mn kinetics during fetal and neonatal development in the human (Figure 1 ). The strategy for modeling Mn kinetics during human pregnancy and lactation was to address the key elements for the successful description of Mn kinetics in the gestation and lactation model that are crucial to predict internal Mn exposure in developing brain (Yoon et al., 2009a,b) : (1) describing placental Mn transfer primarily via active transport while maintaining both the maternal and fetal homeostasis of Mn, (2) describing lactational transfer of Mn using a diffusion-mediated secretion, (3) describing higher gut absorption in suckling neonates, (4) incorporating low but inducible biliary excretion of Mn in neonates, (5) accounting for transition of neonatal features of gut absorption and biliary excretion to those of adults, and (6) allowing enhanced brain uptake of Mn during fetal and postnatal development. Species differences between rats and humans were taken into account for this extrapolation process based on comparative physiology and on age-dependent changes in the pharmacokinetics of Mn.
All model simulations were run using acslX version 3.0 (AEgis Technologies Group Inc., Huntsville, AL). The model code is available from the authors upon request.
Describing Dynamics of Gestation and Lactation Physiology
The descriptions of gestation and lactation physiology in humans were modified or updated from previously published human pregnancy and lactation PBPK models (Clewell et al., 1999; Corley et al., 2003; Gentry et al., 2002 Gentry et al., , 2003 ICRP, 2003) . All physiological parameters are summarized in Table 1 . We also incorporated ventilation changes during gestation and lactation. Alveolar ventilation was increased during late pregnancy by 70% compared with preconception. For the infant and child, recommended pulmonary rates (cubic meters per day) for long-term exposure in children provided in U.S. EPA's ChildSpecific Exposure Factors Handbook (2002), which are based on typical activity levels at different ages, were converted to alveolar ventilation rates assuming that approximately two thirds of pulmonary ventilation is alveolar ventilation. For further details on physiological parameters and the modifications and updates incorporated in the current model refer to the Supplementary data.
To simulate Mn pharmacokinetics during gestation and lactation, all the model simulations were run using female parameters for the maternal body, whereas the fetus and the infant/child were simulated as males because males and females are expected to be similar at this age. The nonpregnant and nonlactating adult females are simply referred to ''adult female'' from this point forward, whereas pregnant and lactating females are referred to as ''lactating female'' or ''pregnant female'', as appropriate. Mn-specific parameters are in Tables 2 and 3 .
Mn Particle Deposition during Gestation and Lactation
The deposition pattern of inhaled Mn particles on nasal and lung epithelium was simulated using the Multiple Path Particle Dosimetry (MPPD) model version 2.0 (Anjilvel and Asgharian, 1995) with the same particle properties used in the adult human male model (Schroeter et al., 2011) . The particle size of 2.0 lm (mass median aerodynamic diameter), a geometric standard deviation of 1.5, and a particle density of 2.95 g/cm 3 were used. Nasal deposition estimated from MPPD simulation was further distributed based on nasal airflow allocation to the respiratory or olfactory epithelium in humans with 5% of the fraction being allocated to the latter (Schroeter et al., 2011) . The same airflow allocation within the nose was applied for all the life stages and ages simulated in the current model.
The default parameters for age-specific airway morphometry and breathing in the MPPD model were used as male representative parameters without modifications, whereas female-specific functional residual capacity (FRC), tidal volume, and breathing frequency for a respective life stage were used instead of the default values to model females (Table 4; ICRP, 2003) . The known changes in FRC and tidal volume during pregnancy were applied in calculating regional deposition of Mn particles in each trimester of pregnancy (Moore, 1994; Spätling et al., 1992) . The pregnancy-induced respiratory changes were assumed to return to nonpregnant levels immediately after delivery. Respiratory parameters and airway morphometry used in the MPPD simulation and the resulting fractional deposition patterns of Mn particles in the lung and nasal cavity in the given life stage are listed in Table 4 . To incorporate the resulting values for life stage-specific or age-dependent changes in fractional depositions, TABLE function in acslX was used to interpolate between the data points produced from the MPPD simulation (Table 4; Supplement table S2) .
Model Structure and Parameterization
The human gestation and lactation models simulated environmental exposure to Mn during pregnancy and lactation for both the mother and the offspring on a normal Mn diet. The basic structure of the current model (Fig. 2) is based on the rat gestation and lactation models (Yoon et al., 2009a,b) . Physiological-and Mnspecific parameters are adopted from the adult human model and appropriately 298 YOON ET AL. adjusted for gestation and lactation periods as detailed in this section (Schroeter et al., 2011) . This section focused on describing the key changes made during extrapolations based on comparative physiology and age-dependent Mn kinetics between the rat and human. A more detailed description of the basic model structure for each life stage is provided in the Supplementary data.
Modeling Females
The current model incorporated higher basal levels of absorption and biliary excretion of Mn in adult females compared with males (Table 3) . One possible explanation for the greater Mn absorption in women relates to reduced iron stores in women that result in greater iron and likely Mn coabsorption than in men (Finley et al., 1994) because iron and Mn are believed to share the same absorption mechanisms, primarily mediated by divalent metal transporter-1 (DMT-1), in the gut . Despite competition at the level of absorption, control of body Mn status appears to occur independently from iron status (Finley, 1999) . Higher absorption and enhanced clearance of Mn in women could be viewed as a consequence of the body's adaptation for the surplus input of Mn secondary to the increased uptake of iron. The kbileC in adult females was estimated to match the basal tissue Mn concentrations with a twofold higher Fdietup than in adult males (Table 3) (Finley et al., 1994) . Basal tissue Mn concentrations in adult females were assumed to be the same as in adult males due to lack of gender-specific data on tissue Mn (Schroeter et al., 2011) . Those steadystate tissue Mn levels were based on the average of male and female values in Sumino et al. (1975) or from other sources in which the genders were not specified . The estimated female-specific Fdietup and kbileC were also used for simulating pregnant and lactating females. Tissue-binding parameters were the same as in the adult males.
Placental transfer of Mn. All the characteristics of the placental transfer of Mn were retained the same as in the rat gestation model with the majority of the transfer being in the maternal-to-fetal direction through active transport mechanisms (Yoon et al., 2009a) . Parameters for this placental transfer of Mn were estimated based on the observed placental and fetal tissue Mn concentrations in late gestation and/or at delivery in humans (Casey and Robinson, 1978; Osman et al., 2000; Takser et al., 2004a) . The estimation criteria were to allow the active transport process to work near its maximum capacity at normal steady state for the pregnant mother on an adequate Mn diet as was done for the rat model (Table 3) . Parameters for maternal-to-fetal flux, both for active transport (VmaxC and Km) and diffusion (ktrans1C), were varied until the active transfer became more than 95% of the flux to the fetal side (Table 3) . Several metal transporters may be involved in this active transfer of essential elements across the placenta, including DMT-1 for iron and Mn, ZnT1 for zinc, and CTR1 for copper (Leazer and Klaassen, 2003; McArdle et al., 2008) . The diffusion clearance parameter from the fetal arterial blood to the maternal placenta, ktrans2C, was set equal to ktrans1C.
The placenta-to-maternal blood partition coefficient, PPla, reflects the high placenta-to-blood ratio of Mn (Takser et al., 2004a) and the experimentally observed Mn trapping in the placenta (Miller et al., 1987) (Table 3 ). This sequestration of Mn in placenta was described in the model by increasing the These values are expressed as fraction of preconception BW, and hence, the actual absolute volumes of these tissues are not changing during gestation and lactation. Fat refers to the separable fat, excluding yellow marrow (ICRP, 2003) .
e These values are expressed as fraction of preconception QC, and hence, the actual absolute blood flows to these tissues are not changing during gestation and lactation. The initial values were not actually zero, but very small numbers close to zero were assigned to prevent floating point errors during the model simulation. placenta-to-maternal blood partition coefficient instead of introducing Mnbinding capacity because the accumulation in the placenta was quite rapid, whereas the washout from the placenta was slow (Miller et al., 1987) . These data suggest simple trapping of Mn in the placenta rather than incorporation into enzymes or cellular constituents that the Mn-binding capacity term represents.
Lactational transfer of Mn. As with our rat PBPK model (Yoon et al., 2009b) , a diffusional clearance from free Mn in mammary tissue (Table 3 ) was used to describe Mn milk secretion. The Mn content in human milk has been positively correlated with increased amount of Mn intake in lactating women, whereas supplementation with zinc, copper, or iron did not influence the milk content of these elements in well-nourished and healthy lactating women (Chierici et al., 1999; Vuori et al., 1980) . These results increased our confidence in the parameter for diffusional clearance even when including inhalation exposure with normal dietary intake. The diffusion rate constant CLmilkC ðl=h=kgBW 0:75 M Þ was estimated to obtain a reasonable model fit against a number of studies available for human milk Mn concentrations during the whole or part of the lactation period in women of several different ethnic groups who were considered on an adequate Mn diet (Arnaud and Favier, 1995; Casey et al., 1985 Casey et al., , 1989 Grebennikov et al., 1964; McLeod and Robinson, 1972; Vuori et al., 1980) (Table 3 ; Fig. 4 ).
Control of Mn gut uptake in neonates. The impacts of early age and/or the molecular forms of Mn in infant food sources on gut absorption of Mn were included in the current human lactation model by adjusting Fdietup using a fractional uptake modifier, FDP (Table 3 ). The FDP was varied depending on the types of infant milk and reflected differences in bioavailability of human milk and cow's milk-based formula inferred from the study by Davidsson et al. (1989) . Human milk was simulated with the highest bioavailability by setting FDP as 10, whereas FDP for cow milk was assigned as 2. The value for Mn-fortified formula milk was 0.01. The Mn content in the milk sources in Hatano et al. (1985) implied that they used nonfortified cow milk-based formula. Thus, the relative bioavailability for this formula was set the same as for cow milk (Davidsson et al., 1989) . On the contrary, the formula used in the study by Stastny et al. (1984) was regarded as an Mn-fortified product. Breast milk was assumed to be the normal diet source for suckling infants, whereas other infant milk sources were simulated only to evaluate the model with existing human blood data (Hatano et al., 1985; Stastny et al., 1984) . The extent of enhancement in gut uptake was reasonably consistent with the findings on neonatal rats and breast-fed human infants (Dorner et al., 1989; Keen et al., 1986) .
Mn movement in the gastrointestinal (GI) tract was also described differently in suckling neonates compared with adults. Although some of Mn in diet are 
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taken up by enterocytes, they are lost into feces before systemic absorption due to the rapid turnover of these cells in adults. Transition of Mn from the enterocytes to the lower GI tract lumen for fecal excretion was extended in suckling neonates due to the slower sloughing rate of these epithelial cells compared with adults. The turnover cycle for GI epithelium (k ENT ) was assumed at birth to be approximately 20% of that for adults and to reach the turnover cycle for adults at weaning (de Zwart et al., 2004; Pacha, 2000; Walthall et al., 2005) . In coordination with this extended transit time, some of the trapped Mn was assumed to be absorbed into systemic circulation before it was lost during sloughing of cells in neonates. This feature was modeled as a delayed absorption of Mn from the neonatal enterocytes to liver using a rate constant, delGI, which was set as 50% of the value of kGI (Table 3) .
The nature of Mn uptake across the GI epithelial barrier in the gut, whether mediated by active transporters and/or other mechanisms, is not sufficiently elucidated to explicitly describe the relative contribution between the fraction absorbed via a direct rapid uptake versus the portion of Mn absorbed through a relatively delayed uptake from enterocytes. Therefore, neonatal GI parameters for Fdietup, FDP, k ENT , F ENT and delGI were Basal biliary excretion rate (kbileC) was assumed to be about 50% of the adult level at birth and became fully mature at weaning in the current model. Neonatal kbileC was adjusted accordingly to this developmental profile using RE ¼ 0.5 þ 1.18 3 days/(180 þ days). Postnatal age was expressed in days in this equation. The enterocyte turnover rate by sloughing was assumed to be about 20% of the adult rate at birth and reach adult value around weaning. These changes were incorporated in the model using KLP ¼ 0.2 þ 0.809 3 (1Àexp (À0.3451 3 (monthsÀ1) ). Postnatal age was expressed in months in this equation.
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parameterized to provide the total fraction of uptake in the suckling neonate at above 60% for human milk Mn (Dorner et al., 1989) for the current modeling implementation.
Describing basal and induced biliary clearance of Mn across ages. The equation for dose-dependent biliary induction in the adult model (Schroeter et al., 2011) was slightly modified to describe the dose-dependent biliary excretion rate (kbile) effective both for basal and induced levels in any life stage except the fetus in the current model as follows:
where kbile0 is the basal biliary excretion rate at normal steady state, k bmax is the maximum fold of induction for the biliary excretion rate, and k b50 is the arterial concentration (C art ) of Mn at half of the maximal induction. The n is the hill coefficient that determines the slope/shape of the dose-response in biliary induction against the C art of Mn. The f app is to reflect the apparent level of biliary excretion of Mn as a fraction of the basal, i.e., true biliary excretion rate of Mn. The apparent rate of biliary excretion of Mn is very low in neonates. Consequently, only a fraction of the normal capacity is in effect, as represented by the product of f app and kbile0. The actual biliary excretion rate (kbile) at steady state C art is equal to the basal excretion rate (f app 3 kbile0) because there will be little or no contribution from the induction part of the equation in the basal state. The value for f app is 1 for adults, whereas it is reduced to 0.001 in neonates. This reduction was to reflect Mn homeostasis in nursing neonates to ensure adequate Mn supply in response to a limited supply from breast milk as observed in animals Ballatori et al., 1987) and also to be consistent with the observed neonatal tissue Mn in humans assuming the mother's milk was the only Mn source for nursing infants (Bonilla et al., 1982; Casey et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) . The BW 0.75 normalized basal biliary excretion rate constant (Table 3) is kbileC (l/h/kg BW 0.75 ). The kbileC in neonate was set at birth as 50% of the adult level to reflect the immaturity of biliary function during early neonatal period and increased to an adult level around weaning, the developmental pattern of which is described using an equation RE (Table 3) .
The concentration of Mn in the umbilical cord and in the newborn blood is known to be higher than in the mother or in normal adults and is consistently elevated in blood during early infancy through later childhood (Hatano et al., 1983; Henn et al., 2010; Rukgauer et al., 1997; Spencer, 1999; Takser et al., 2004a; Zota et al., 2009 ). Based on this higher basal concentration of blood Mn during normal growth, the curve for describing the biliary excretion rate against the blood Mn concentration (Equation 1) was shifted to the right for early ages to reflect the difference in basal blood Mn concentration compared with adults, i.e., biliary excretion is at basal level during normal lactation despite the high blood Mn concentration compared with adults. This shift was made by increasing the constant k b50 about 2.5 times greater than that for the adults to allow higher basal concentration of Mn in whole blood in the fetus/neonate compared with the mother (Spencer, 1999; Takser et al., 2004a; Zota et al., 2009) . Most blood Mn is associated with erythrocytes, and the rise in these cells is responsible for the elevation of blood Mn during early ages (Hatano et al., 1983) . Because the blood compartment was modeled as a whole compartment without subcompartments in it, Mn in erythrocytes was considered as part of the readily available free Mn in the whole blood in the current model. For adults, QP (liters per hour) was calculated as (tidal volume À dead space volume) 3 breathing frequency. The dead space volume for adults were reported in ICRP publication 89 was used (ICRP, 2003) . BW for the respective ages and gender was obtained from the current model. They were used in calculating the scaled alveolar ventilation (QPC, liters per hour kilograms). Respiratory parameters for resting humans in the MPPD model were used without modifications when simulating the exposures for males. For the female adults, female-specific FRC (2.7 l), breathing frequency, and tidal volume at sitting awake state adopted from ICRP data were used (ICRP, 2003) . For pregnant females, appropriate changes were made to include pregnancy-induced changes in FRC and tidal volume, details for which refer to Supplementary Data (Moore, 1994; Spätling et al., 1992 ).
e Human symmetric and age-specific symmetric models in MPPD software were to simulate Mn particle deposition in the adult and young, respectively. MPPD simulations produced the deposition fractions in head, trachiobronchial, and pulmonary regions. The fraction of Mn particles deposited in head was used to obtain the total nasal cavity deposition, whereas the fractions in TB and p were added together to obtain the total lung deposition.
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Transition of neonatal gut uptake and biliary excretion to adult levels. The transition of neonatal features of fractional uptake and biliary excretion to those of adults occurs in coordination with GI functional changes, which are mainly caused by changes in the diet, i.e., from milk to adult foods. These transitions were modeled as occurring abruptly at around 6 months after birth, when the neonates were considered weaned. After weaning, FDP was no longer applicable and f app becomes 1 (Table 3) .
Tissue binding of Mn during fetal and neonatal development. In the current model, the tissue-binding property of Mn in each tissue was a reflection of the changes in the expression of proteins or other cellular constituents in parallel with the needs for Mn for different biological functions during growth. The tissue-binding parameters in the fetus were modeled to be consistent with the data from fetal autopsy tissues (Casey and Robinson, 1978) and with their relative level compared with adults (Casey et al., 1982) . Human tissue Mn levels in young infants and children were comparable to or even higher than in adults (Bonilla et al., 1982; Casey et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) . Thus, tissue-binding parameters in neonates were varied to be consistent with the observed neonatal and adult Mn tissue levels.
Mn content in bone showed the greatest difference between the fetus and adults (Casey and Robinson, 1978) . This probably reflects different composition of bone during early development and also higher demand for Mn for proper skeletal growth in utero (Hurley, 1981) . The BmaxC values for the bone and the rest of body compartment (Table 2) were increased in the fetus to be consistent with the observed fetal bone and skeletal muscle Mn data (Casey and Robinson, 1978; Casey et al., 1982) . Fetal skeletal muscle concentration was used as a surrogate for the rest of body Mn content. Moreover, the ka for fetal bone was increased to be consistent with the observed fetal bone Mn concentration, increase of which reflects more cartilage-like composition of fetal bone (Casey and Robinson, 1978) . In this regard, the bone-to-blood partition coefficient was also increased during gestation ( Table 2 ). The higher BmaxCs of the fetal bone and the rest of body gradually decreased, reflecting developmental changes in tissue composition and metabolism in these tissues. The released Mn from these presumed prenatal pools was redistributed to other tissues and consequently met the Mn requirement in various tissues in neonates, especially during lactation, during which no Mn input other than mother's milk was available. The rates of this release were adjusted assuming that Mn content in the bone reaches an adult level at approximately 1 year after birth, whereas other neonatal tissue Mn levels are already comparable to those of the adults during breast-feeding and subsequent postnatal growth after weaning (Bonilla et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) . Increases in hair Mn concentration during the first 3 months of life that were independent of dietary Mn intake suggested a redistribution of Mn from prenatal body stores during this time (Gibson and DeWolfe, 1980) . Hair Mn levels declined during the 3-to 6-month period of infancy, which may imply that the redistribution of ''stored'' Mn may largely be completed and/or the intake at this time might be insufficient (Gibson and DeWolfe, 1980) . For other tissues, BmaxC, ka, and kd (Table 2) were adjusted to fit the observed tissue Mn concentrations in the fetus and neonate Casey and Robinson, 1978; Sumino et al., 1975; Widdowson et al., 1972) .
Parameters for Mn influx, efflux, and tissue-binding kinetics in fetal and neonatal brain. The globus pallidus, cerebellum, and olfactory bulb were included based on the following criteria as in the adult: (1) being a target for potential Mn neurotoxicity, (2) representative of general brain tissue, or (3) a region with potential contributions from direct transport from the olfactory epithelium (relevant only for neonatal, not fetal brain), respectively. The fetal and neonatal parameters for brain diffusion and tissue binding in these three different regions were adjusted to match the reported brain Mn concentration at birth (Casey and Robinson, 1978) and postnatal changes that imply neonatal brain Mn being comparable to adults (Bonilla et al., 1982; Tingey, 1937) . The kin and kout were varied to ensure sufficient Mn influx into the developing brain without negating the presence of an immature blood-brain barrier. This was achieved by keeping the ratio of kin/kout lower than in adults. Thereby, the fluxes of Mn in developing brain were enhanced in both directions. This approach reasonably captured developmental stage-specific brain Mn kinetics both at normal and excess Mn exposures in the rat (Yoon et al., 2009a,b) . The ka in each fetal brain region was also increased in parallel with the greater requirements for Mn during active brain development (Table 2) . Although the majority of neurodevelopment occurs in utero in humans, some of the development processes are known to continue after birth (U.S. EPA, 2001). To reflect this, the ka values in neonatal brain were higher than in adults as long as the model simulation matched the published brain Mn concentrations during the perinatal period (Casey and Robinson, 1978; Casey et al., 1982; Tingey, 1937) . In addition to their total brain Mn level being similar to adults, Mn in the corpus striatum region in human infants and children is higher than in other brain areas as occurs in the adult brain (Bonilla et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) , which was reproduced reasonably with the current tissue-binding parameters for the brain ( Table 2 ). The fraction bound in fetal and neonatal brain was more than 0.7 as in the adults (Schroeter et al., 2011) .
The description for the free Mn-dependent influx control in the globus pallidus region used in the adult male model was kept similar when simulating all the life stages in the current model. The kinMax, the maximal fold of induction, was slightly reduced in the fetus and neonate. The kin50 values were retained the same as the adult male due to limited data on this additional layer of brain Mn control, especially during gestation and lactation (Table 2) .
Model Simulation
Exposure before pregnancy. In order to obtain a steady-state body burden of Mn before pregnancy, the preconception period was first simulated. The model was run for a sufficiently long duration so to have tissue Mn levels reach a steady state for the given inhalation concentration. Tissue Mn levels are expected to be maintained relatively constant during continuous Mn inhalation due to induction of biliary excretion of Mn in response to excess Mn from inhalation exposure, albeit this newly achieved steady state could be higher than the normal steady state with only dietary exposure depending on the exposure level.
Steady-state kinetics with normal dietary Mn exposure. Adults were assumed to be on a 3 mg Mn/day diet regardless of their life stages, e.g., preconception, pregnancy, and lactation. No additional intake of Mn from other supplementary sources was included during pregnancy or lactation. For nursing infants, Mn intake was solely from breast milk during the first 6 months after birth. For postweaning infants and children, Mn intake from diet was assumed to be 2 mg Mn/day in the model based on published tolerable upper limit of recommended daily Mn dietary intakes for children between 1 and 3 years of age (The National Academies and zinc, 2001).
Inhalation scenarios for environmental Mn exposure. Environmental Mn exposure was simulated as continuous inhalation of ambient air Mn either at 0.001 or 0.01 mg Mn/m 3 in addition to the normal background Mn exposure from food or milk. The former concentration was considered as a relatively high level of ambient air Mn (i.e., it is 20-fold higher than the current EPA inhalation reference concentration (RfC) for Mn), whereas the latter is a polluted level of air Mn that is close to the lower end of the occupational exposure range. MnSO 4 particles were selected for model simulation to be conservative in simulating inhalation exposure to Mn in ambient air. They are highly soluble in mucus and tissue (Vitarella et al., 2000) and are shown to result in higher brain Mn concentration compared with other less soluble forms of Mn (e.g., MnO2, MnPO4) (Dorman et al., 2001) . Environmental exposure was simulated as a continuous inhalation to Mn throughout preconception, pregnancy, and lactation for the mother. For the offspring, the exposure by inhalation on their own started at birth and continued during lactation and postnatal growth after weaning. In some cases, inhalation exposures at 0.1 or 0.5 mg Mn/m 3 were simulated for model evaluation purposes.
Predicting Mn tissue dose metrics during gestation and lactation. Total tissue Mn concentration and daily average area under the curve (AUC; microgram hours per gram per day) were selected as Mn internal dose metrics in the target brain region, the globus pallidus. These two dose metrics were reported either as time course profiles or for four selected representative life stages. The four life stages were the end of pregnancy, the 4 months of lactation (both for the mother and neonate), and 3 years after birth to represent the pregnant mother/fetus, lactating mother/suckling infants, and growing child, respectively. The globus pallidus concentration was obtained at the end of each simulation after running the model for appropriate durations for the selected life stages. The daily dose of Mn (milligrams of Mn per kilogram per day or milligrams of Mn per day), which is the total systemically available dose of Mn through various routes, was also obtained using the model and was compared among different life stages. The daily dose on day i for each dose route was calculated as a difference in the cumulative doses between day i and day i-1 , where day i represents the respective simulation duration for each representative life stage selected in current modeling as described above.
Model Evaluation
Evaluation criteria were utilized to determine whether model predictions are reasonably consistent with currently available human observations and knowledge of the biology of Mn and other essential elements in animals and humans. The human blood data used for the model evaluation were not directly utilized to estimate any of the model parameters. The blood concentration of Mn is determined as a result of the steady-state Mn kinetics in each tissue, between the tissues and blood, and between intake and biliary excretion. Thus, the goodness of the model fit to these blood data was considered to reflect the integrity of the model structure overall and to thus ensure the validity of the approach used in model parameterization. The goodness of the model prediction was examined visually. To the extent possible, the ability of the model to consistently describe time-dependent changes in tissue Mn levels during postnatal development and the relative levels of Mn between maternal and offspring tissues were assessed as well as the correspondence between the model predictions and the observed data at specific ages/life stages.
Evaluation with human data. Human data were used for the model evaluation include maternal, umbilical cord, or neonatal/children blood Mn concentrations (Hatano et al., 1983 (Hatano et al., , 1985 Henn et al., 2010; Krachler et al., 1999; Rukgauer et al., 1997; Spencer, 1999; Stastny et al., 1984; Su et al., 2007; Takser et al., 2004a; Wilson et al., 1992; Zota et al., 2009) . For some studies, whole blood concentration was reported, but others determined Mn levels in serum/plasma or erythrocytes. We used whole-blood Mn predictions for comparison to these data assuming that change in serum/plasma or erythrocyte Mn parallels that of whole blood across life stages. The umbilical cord blood Mn level was considered to reflect the Mn level found in fetal blood.
Sensitivity and uncertainty analysis. A sensitivity analysis was performed as described in the previous study (Yoon et al., 2009a) . Normalized sensitivity coefficients (SCs) for the four selected life stages were reported to convey the time dependence of the various model parameters on Mn kinetics during development and hence to gain insights into the relative importance of the given parameter on the brain dose metrics during fetal and neonatal development. The analysis was conducted for a diet-only exposure or for a combined exposure of diet and inhalation at 0.01 mg/m 3 to compare the SCs between the steady-state and inhalation exposures. All the model parameters were subject to the sensitivity analysis, and those with an SC greater than 0.2 were reported (Tables 6 and 7 ). The same criteria applied in the rat model to categorize the SCs into low, medium, or high sensitivity were followed in the current analysis. The uncertainty was designated as follows (Tables 6 and 7) : Low (L): Data were directly available for the parameter or the value was optimized using relevant human tissue Mn data Medium (M): Information on pharmacokinetics of Mn available and.or underlying biological processes relevant for the parameter available for Mn. The values for 3-to 4-day-old neonates. Maternal blood Mn data were collected at delivery in Takser et al. (2004b) and Zota et al. (2009) , but at 34 weeks of gestation in Spencer (1999) study.
FIG. 2.
Model structure to simulate Mn biokinetics in the pregnant adult, developing fetus, lactating mother, nursing neonate, and growing child with combined exposure to Mn via diet and inhalation. Mn presents either as free (Mnf) or bound (Mnb) in the body. The letter ''B'' represents Mn-binding capacity in the tissue. Free Mn circulates in the blood, whereas bound Mn is stored in the tissue. Fractional uptake/deposition from diet or inhalation and the fate of Mn not absorbed in the gut lumen from diet are also depicted in the diagram for the mother and neonate/child. Fetal blood circulation was modeled as separate from that of the mother. Six months of exclusive breast-feeding was simulated followed by an immediate switching to consumption of adult food for the neonate/child model. Maternal Mn is transferred to the fetus or to the neonate through placenta or milk, respectively, in the free form. Subscript ''F'' or ''N'' denotes parameters for the fetus or the neonate/child, respectively.
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High (H): Data were not directly available for Mn. Reasonable assumptions can be made based on the information for other essential elements or related bilogical processes relevant for the parameter description or all others.
RESULTS
Model Simulation
Changes in placenta and fetal tissue Mn during inhalation. The current model predictions compared well with the reported Mn concentrations in the placenta and in several fetal tissues in late or at the end of gestation without inhalation exposure in the mother (Fig. 3) . Placental and fetal tissue Mn concentrations were simulated for three different inhalation exposures at 0, 0.001, and 0.01 mg Mn/m 3 (Fig. 3) . Placental Mn concentration did not change following exposure to 0.001 mg/m 3 but increased at 0.01 mg/m 3 by 18% over the steady-state value, which still falls within the normal variation (Takser et al., 2004a) (Fig. 3) . The corresponding increase in fetal globus pallidus Mn was even smaller, approximately 11% of the normal control in the simulated 0.01 mg/m 3 inhalation scenario (Fig. 3) . Although Casey and Robinson (1978) reported the whole brain concentration and the model simulations were for the globus pallidus, the incremental increase in globus pallidus Mn appears to fall within the expected normal variation judging from the extent of variation in whole brain. (Fig. 4) was consistent with the observed human data (Arnaud and Favier, 1995; Casey et al., 1985 Casey et al., , 1989 Grebennikov et al., 1964; McLeod and Robinson, 1972; Vuori et al., 1980) . With 0.01 mg/m 3 inhalation, the change in simulated Mn concentration in late milk was less than 10% compared with that in the diet-only exposure (Fig. 4) .
Predicting neonatal tissue Mn with or without inhalation exposure. While the simulated neonatal globus pallidus concentration in children after weaning was comparable to adults, it was lower than adults during nursing probably due to the marginal body Mn status in suckling neonates (Fig. 5) . The projected increase in brain Mn in the simulated 0.001 mg/m 3 inhalation scenario fell within the range considered normal for this age, i.e., the level comparable to adults because the neonatal brain Mn concentration appears to be similar to that of the adults (Bonilla et al., 1982; Casey et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) . The extent of the increase seen in the high environmental exposure simulation at 0.01 mg/m 3 was regarded, however, as a significant deviation from the normal concentrations as in the adult (Figs. 5 and 6 ). Liver Mn concentration in children from birth to 3 years of age was predicted to be also somewhat lower during lactation but did not show as much of an increase as the brain under inhalation exposures (Fig. 5) .
Predicting neonatal brain Mn above the environmental exposure range. To examine whether fetal or neonatal brain Mn changes in response to high doses of Mn inhalation are different compared with adults, two additional concentrations that fall within the occupational exposure range, one at 0.1 mg/m 3 and the other at 0.5 mg/m 3 , were simulated. Neonatal brain exhibits a dose-response pattern similar to that of adults, showing Mn accumulation starting at around 0.01 mg/m 3 for both nursing infants and growing children (Fig. 6) . The predicted dose-related changes in fetal brain Mn were less stiff than in the adults (Fig. 6 ). These simulations support that no appreciable accumulation of Mn is expected under typical environmental Mn exposure during the postnatal period.
Comparison of Mn internal exposures across life stages. Average expected daily AUCs for the globus pallidus were compared among life stages both for control and two environmental Mn exposure levels (Fig. 7) . 
Note. Criteria for sensitivity designation were the same as described in Table 6 . Pregnancy and lactation did not greatly affect the internal dose of Mn in the brain simulated from the model. The average daily AUCs were greater in men than in women at high-dose environmental exposure of Mn, i.e., exposures where brain Mn concentration started to rise from the basal level. The internal dose of brain Mn in suckling infants was different than that in other life stages. Due to the lower basal level, the relative increase in brain AUCs appeared to be greater in this period. However, it would be more reasonable to consider that breast-fed infants are at a rather marginal deficient Mn status, evidenced by the homeostatic control retaining as much Mn as possible by enhanced uptake and restricted biliary excretion.
Comparison of Mn doses among different exposure sources. The daily dose of Mn through various routes of exposure, such as placental transfer, milk, diet, or inhalation, was compared for four different life stages (Fig. 8) . The total systemically available Mn dose was used for comparison because it provides a better means to examine the relative contribution of different routes for total Mn dose in the adult and the young than the external dose. These simulations indicate that there would be no significant increase in placental dose to the fetus following maternal exposure to 0.01 mg Mn/m 3 . The relative contribution of milk Mn in neonates was very small even when the mother was subject to inhalation exposure. In nursing infants, relative contribution of the inhalation route to the total dose of Mn appeared significantly greater than their normal intake route, i.e., milk consumption. However, it should be noted that redistribution of Mn from the bone and muscle has to be considered as another source for Mn in suckling infants in addition to the apparent input from milk. Both in adults and children after weaning, the relative contribution of inhalation (0.01 mg/m 3 ) was smaller than their normal dietary intake at these inhalation exposures.
Model Evaluation
Evaluation with human blood data. The performance of the model was evaluated using reported human blood Mn concentrations at steady state during gestation and lactation. The model-calculated fetal blood concentration (Table 5 ) was close to the cord blood concentration at birth in several different studies (Su et al., 2007; Takser et al., 2004b; Zota et al., 2009 ). In addition, we reproduced the relatively higher Mn in fetal blood compared with maternal blood and the subsequent decrease in blood Mn during the postnatal period (Fig. 9) . Model-predicted whole-blood Mn concentrations during the postnatal period (Fig. 9 ) were plotted together with reported whole blood concentrations to show the timedependent profiles of blood Mn (Henn et al., 2010) . The pattern of the decrease in whole-blood Mn during the postnatal period compared well with the data from children (Henn et al., 2010; Spencer, 1999) . The predictions (Fig. 9) were also consistent with the observed profiles of erythrocyte Mn change in infants (Hatano et al., 1983) . However, blood Mn in the pregnant mother was under predicted by the current model (Table 5) . Considering the limited information on underlying mechanisms for increased blood Mn during pregnancy, we were reluctant to make significant changes in Mn absorption and excretion processes during pregnancy, and thus, we did not attempt to fit the pregnancy model to the blood Mn data. For further discussion on the increase in blood Mn during human FIG. 3 . Model-simulated placental and fetal tissue Mn concentrations at the end of gestation with different environmental exposure scenarios. Note that whole-brain Mn concentration was reported in Casey and Robinson (1978) , whereas the model simulation was for globus pallidus concentration. Empty columns with error bars represent the mean ± SD of Mn concentration in the given tissue reported in Casey and Robinson (1978) , whereas filled columns indicate model simulations. For placenta and globus pallidus concentrations, model simulation results for 0, 0.001, and 0.01 mg Mn/m 3 inhalation exposures were plotted, whereas for other tissues, only the results from basal state simulation, i.e., 0 mg Mn/m 3 inhalation and diet-only exposure to the mother, were presented. Evaluation of the model using serum or erythrocyte Mn data measured in formula-fed or breast milk-fed infants implied that the current descriptions on fractional uptake and biliary induction in neonates were consistent with higher-dose exposure by oral ingestion in nursing infants. The predicted whole-blood Mn concentration in infants fed on breast milk during the first 5 weeks of ages was 83% of that simulated for cow milk-based formula-fed infants, a difference consistent with findings of erythrocyte Mn in humans (Hatano et al., 1985) . Mn exposures in infants described in Stastny et al. (1984) study were simulated using the current model. Model-predicted whole-blood Mn concentrations in breast milkfed infants were about 80% of that in formula-fed infants, which was in agreement with their observation of serum Mn in breast-fed infants being 84% of that from formula-fed infants.
Overall, reasonable correspondence was observed between the model-simulated and reported tissue Mn concentrations in humans indicating that the current model structure and parameter values are reasonable, although the model parameters were not optimized by rigorous statistical approaches.
Sensitivity analysis. Sensitivity and uncertainty analyses evaluated the influence of the model parameters on the Mn concentration and daily average AUC for globus pallidus (Tables  6 and 7 ). The most sensitive parameter for the fetal globus pallidus dose metrics was the maximum rate of placental transfer by the active processes. The uncertainty designation of this parameter was medium, however, considering the extent of data used for estimating this parameter. The key parameters for fetal brain Mn were similar between the control and inhalation exposure reflecting that the dose we simulated did not cause significant changes in Mn concentration in the fetal brain. Other parameters that are influential for the given dose metrics in the fetus are brain diffusion parameters and the maximum binding capacity in the globus pallidus, bone, and other tissue compartment; an observation that emphasizes the importance of describing fluxes across the blood-brain barrier and the role of Mn storage in utero in determining brain Mn level both at steady-state and at moderate inhalation exposures. In contrast to the neonatal brain dose metrics, maternal uptake and elimination parameters affected the fetal brain dose metrics. The reason for this difference may be related to the fact that the role of milk Mn in neonatal Mn status is minimal, unlike the placental Mn delivery, which is the sole source of fetal Mn. Brain diffusion and binding parameters continued to have high sensitivity for the globus pallidus dose metrics in suckling infants and growing children. The importance of accounting for the elevated basal blood Mn in neonates was confirmed by the impact of this parameter on predicting neonatal brain Mn dose metrics. Confidence in the physiological parameters that were found to be influential for brain dose metrics was considered high because they are based on measured data.
DISCUSSION
The key question to be addressed in any model to assess potential sensitivity of the developing brain to Mn is dosedependent changes in homeostatic control of Mn in the young, i.e., at what exposure level do we see a transition from normal steady state to overexposure conditions? This key feature arose in modeling of rat gestation and lactation and was successfully addressed by capturing the underlying biology and physiology of this essential element homeostasis during pre-and postnatal development as part of the model. Similarly, our human model provides a means to evaluate several alternative descriptions of the homeostatic control mechanisms during gestation and lactation in humans both for normal steady state and overexposure to Mn. The best plausible description for Mn homeostasis in growing humans was incorporated in the final form of the model to predict brain Mn dosimetry in infants and children.
Mn Homeostasis during Fetal and Neonatal Development
For the fetus and neonate, ensuring sufficient Mn supply from the mother through placenta and milk is the most critical aspect in Mn homeostasis while keeping tissue Mn stable in response to the large daily fluctuation of intake of Mn from the diet rich with this element is the most central part in the case of adult. The essence of our findings on the fetoplacental transfer of Mn in the rat gestation model was that the drivers for this transfer ensured adequate supply of this essential element to the developing fetus as well as maintenance of maternal homeostasis (Yoon et al., 2009a) . The role of active/carrier-mediated transport in the current model is much greater than that of diffusion both at basal steady state and up to a relatively high inhalation exposure, consistent with conclusions from the rat model (Yoon et al., 2009a) . These carrier-mediated transport mechanisms may be regulated to meet developmental requirements in the fetus when maternal Mn intake ranges from the marginally deficient to the sufficient range and to prevent excessive transfer of Mn to the fetus if maternal Mn status increases to abnormally high levels. Although the placenta efficiently transfers Mn to the fetus at normal steadystate exposure, this organ appears to limit Mn transfer to the fetal circulation in the case of maternal high-dose exposure as shown by the accumulation of Mn in human placenta in vitro (Miller et al., 1987) as well as in rhesus monkey placenta in utero (Kay and Mattison, 1986) . As a result, the increase in fetal tissue Mn was disproportional to the changes in the placenta as Mn dose increases, resulting in no appreciable accumulation of Mn in the fetus during typical environmental Mn exposures (Fig. 3) .
It is challenging for human neonates to gather adequate Mn to meet the requirements for normal growth due to low Mn content in human milk compared with other species . The possibility of maintaining tissue Mn as observed in human neonates with breast milk only was tested with our model. Even with 100% bioavailability assumed for breast milk, the simulations could not reach tissue Mn levels observed in human neonates and children (Bonilla et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) . As in the animal studies (Widdowson, 1974) , this discrepancy indicates that the bone and muscle seem to play a key role in providing Mn for other tissues with higher demands such as the brain in response to the low concentration of this essential element in breast milk (Casey et al., 1982; Vuorinen et al., 1996) . Judging by their growth and maturation characteristics, requirements for Mn by these tissues decrease during postnatal development. Thus, the Mn accrued in those tissues prenatally is redistributed into other tissues. With this feature included, model simulations were consistent with the observed tissue Mn in humans at early ages for the bone and other tissues (Bonilla et al., 1982; Lehmann et al., 1971; Reiman and Minot, 1920; Tingey, 1937) .
Because Mn sources other than breast milk were not included, simulated brain Mn during lactation could be considered to represent the lower end of normal variation in neonatal brain. Although it is difficult to define what brain concentration would be ''normal'' for nursing infants, a level close to that of adults is likely an appropriate assumption because the fetal brain concentration was already similar to the adult level and there is no evidence in terms of either data or in the biology of brain development which indicate significant changes in brain Mn during the early postnatal period. In this regard, the small increase in brain Mn predicted during inhalation exposure at a low concentration (Fig. 5) was not surprising and was considered still within the normal range during breast-feeding. As in the adult, brain Mn was estimated to be increased in nursing infants at higher inhaled Mn concentrations (Fig. 5 ).
Fetal and Neonatal Brain Mn
The apparent enhanced ''permeability'' of certain metals in the developing brain may not simply be caused by the immaturity of adult barrier mechanisms (Ballatori, 2002; U.S. EPA, 2001) . The uptake of compounds in the developing brain appears to be controlled by mechanisms distinct from the adults, thus allowing greater uptake of compounds required during development, such as amino acids and growth factors (Dziegielewska et al., 2000; U.S. EPA, 2001) . Active transport of Mn across the blood-brain barrier is an example of specialized processes in place to meet the requirement for this element for normal brain development. The expression of transporter proteins known to be responsible for an active uptake of Mn and other essential elements appears comparable to or greater in fetuses/neonates than in adults (Erikson et al., 2007; Siddappa et al., 2002) . Among other potential transporters, DMT-1 and transferrin receptor proteins are regarded as major contributors to Mn transport (Erikson et al., 2007; Garcia et al., 2006) . The elevated expression of these transporters likely results in the elevated influx of Mn into the developing brain compared with the adults. As in the rat modeling (Yoon et al., 2009a,b) , this model for the human fetus and neonate successfully captured this feature by changing the influx/efflux diffusion rate constants and the association rate constant in fetal and neonatal brains.
To extrapolate the rat findings to simulate human brain Mn, particular caution is needed to account for differences in the timing of neurodevelopment. Brain development continues into the postnatal period in the rat. The first week of postnatal period in the rat is believed to equate to the third trimester in humans (Clancy et al., 2007) . However, some neurodevelopment continues into the first year or so of life in humans (U.S. EPA, 2001) . This human Mn model accounted for a more mature stage of the human brain during the early postnatal period by varying the brain diffusion and binding parameters compared with the rat (Yoon et al., 2009b) . These modifications reflect the age-specific expression patterns of Mn transport proteins in the brain barrier and biological functions that are developmental period specific. The current brain uptake and diffusion parameters described basal brain tissue Mn in the fetus and neonate and the changing patterns during postnatal development. Our success in developing the rat PBPK model indicated that these brain uptake parameters were applicable to the inhalation exposure conditions without requiring dose dependencies for brain fluxes. We maintained this description of these processes in scaling the model to humans.
Regulation of Gut Uptake
The enhanced gut uptake of Mn seen in the neonates (Dorner et al., 1989) appears to be largely reflective of the developmental requirements for Mn. This enhanced uptake is likely mediated by the expression of specific receptor proteins, rather than a consequence of immaturity of epithelial barriers (Pacha, 2000) . The homeostatic control of Mn gut uptake during lactation is different in nature from that of the adult. The neonatal gut regulates Mn absorption by expressing receptors for proteins that bind Mn in human milk, rather than sensing Mn concentration/amount in food by way of DMT-1 as occurs in the adult (Chan et al., 1982; Lonnerdal et al., 1985) . The receptor-mediated uptake of lactoferrin-bound Mn into the intestinal brush border membrane has been demonstrated, and the ontogeny of corresponding receptor expression in humans supported a role of lactoferrin, the major Mn-binding protein in human milk (Lonnerdal et al., 1985) , in enhanced Mn bioavailability from human breast milk Lonnerdal, 1988, 1989; Pacha, 2000) . Although mediated through a different process, neonatal gut still controls Mn homeostasis based on body Mn status. This conclusion is consistent with iron uptake in neonates where the needs for this element determine the degree of absorption (Lynch et al., 2007) . This regulation mechanism by the types of binding protein in milk could potentially play a role in minimizing the influence of dietary Mn deficiency during nursing when DMT-1 is poorly responsive to essential element requirements as seen with iron (Collard, 2009; Shannon, 2006) . In addition to regulating the percentage of Mn absorption, the form of Mn-binding protein in infants' diets is another cue for switching from the neonatal pattern of transporter expression to the adult pattern on weaning (Pacha, 2000) . The ability of our model structure to capture Mn source-specific regulation of gut uptake in nursing infants will be useful for evaluating the consequences of different levels of Mn in infant formula and/or infant food on tissue Mn.
Control of Mn Biliary Excretion
The current parameterization of neonatal biliary excretion and induction is consistent with a key feature for neonatal homeostasis. In this case, the lack of basal biliary excretion during early postnatal period occurs because of the low level of Mn in mother's milk compared with the adult diet. The neonates are still able to excrete Mn when overdosed. This behavior is just as applicable for human neonates as for the young animals (Ballatori et al., 1987 et al., Kostial et al., 2005 . The biliary excretory pathway does appear to be fully developed in the human infants; it is inducible when challenged with excess Mn by several different exposure routes, i.e., ingestion of high Mn content food, such as formula HUMAN PBPK MODEL FOR MN DURING GESTATION AND LACTATION milk Hatano et al., 1985; Sampson et al., 1983; Stastny et al., 1984; Zlotkin and Buchanan, 1986) .
Because we had dose-dependent biliary excretion controlled by blood Mn in the model, it is critical to take into account the elevated basal blood concentration in infants and children compared with the adult to properly depict this key homeostatic mechanism. This was accomplished by applying a higher dissociation constant for biliary induction for infants and children. This alteration captured the increased steady-state blood levels in neonates. However, the responsiveness of biliary induction at much higher exposures may underpredict the actual induction capability.
Conclusions
Collectively, we have integrated knowledge on fetal/neonatal Mn kinetics and successfully described early life Mn homeostasis during human development and growth. The critical components in this integration included (1) Mn kinetics in the developing organism are determined by the requirements for this element during normal growth, (2) homeostatic control of Mn kinetics at normal steady state are different from those in the adult due to different Mn requirements across life stages, and (3) infants and children are able to respond to overexposure to Mn in a similar way as the adult. The current model provided estimates for fetal and neonatal Mn target tissue dosimetry under various inhalation exposure conditions together with dietary exposures. In general, similar or lower internal exposures to Mn in fetal and neonatal brain are predicted compared with the adult for the various exposure scenarios examined.
Future Directions
Confidence in predicting target tissue dose metrics during human development with this PBPK model could be improved if more information becomes available regarding (1) the normal range and fluctuation of brain Mn concentration during the early postnatal period of relative Mn deficiency, (2) the relationship between blood Mn concentration and target tissue dosimetry, and (3) the extent of neonatal biliary induction at higher exposure conditions. Although blood Mn is the most accessible biomarker for humans, correlating estimates of target tissue concentrations could be obtained, for example, from magnetic resonance imaging studies of Mn in infants due to TPN. This type of data could further enhance the understanding of target brain tissue Mn levels in infants during overexposure conditions.
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